Our section’s focus is to develop biomedical optics technologies that non-invasively characterize tissue hemodynamics and translate them to a point-of-care setting.

Video-based Mouse Activity Monitoring and Behavior Profiling

Development of Imageable and Thermochromic Phantom for Needle Guidance during Ablation using Augmented Reality

The Center for Interventional Oncology (CIO) (http://www.cc.nih.gov/centerio/index.html) offers new and expanded opportunities to investigate cancer therapies that use imaging technology to diagnose and treat localized cancers in ways that are precisely targeted and minimally- or non-invasive. The Center for Interventional Oncology (CIO), under the leadership of Dr.

The Center for Interventional Oncology (CIO)

The laboratory is focused on the study of cancer and the development of new and improved treatments for currently incurable cancers. The current project is focused on colorectal cancer, a leading cause of cancer death. Recently, we have discovered a vulnerability of colorectal cancer cells and exploited this discovery to develop two experimental drugs that effectively induce cell death in colorectal cancer cells. Briefly, Eph receptors are a family of tyrosine kinase cell surface receptors expressed in colorectal cancer cells.

The Tanner lab is focused on the early stages of metastasis, when one or a few cells have migrated from the primary tumor and survived transport in blood and lymph vessels to colonize distant organs. In the field of mechanobiology, mechanical properties have been shown to modulate gene expression and phenotype and thus influence cell fate decisions.

Meta-learning based Diagnosis of Rare Cancers from MRI Images
 

Deciphering the chemo-mechanical properties of myosin-6 using scattering and fluorescence single molecule techniques